Codexis, Inc. (CDXS)
Last updated: 2026-10-27 10:29:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Summary
Codexis, Inc. (CDXS) operates in the INDUSTRIAL ORGANIC CHEMICALS sector and is listed on NASDAQ. The stock is currently priced at $1.31, with a market capitalization of $140.17M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.96 to $2.98. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$140.17M | |
$1.31 | |
$42.01 | |
$0.96 | |
$1.30 | |
3.00 | |
931.03K | |
-- | |
$2.98 | |
$0.96 | |
-- | |
-- |
Codexis, Inc. (CDXS) Pre-Market Stock Price
Codexis, Inc. (CDXS) is trading at $1.31 in pre-market trading as of 2026-10-27 08:48:00, up 0.77% ($0.01) from the previous close of $1.30
Pre-market trading shows how investors are pricing CDXS before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Codexis, Inc. (CDXS) 7-Day Stock Price Change
Over the past seven days, Codexis, Inc. (CDXS) moved from $1.24 to $1.31, representing a gain of 5.65% ($0.07).
The stock traded between $1.21 and $1.36 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 846.81 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
CDXS 52-Week Price Position
Position in Range: 17.4%
CDXS is currently trading at $1.31, placing it 17.4% of the way from its 52-week low of $0.96 to its 52-week high of $2.98. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Codexis, Inc. (CDXS)?
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.
Codexis, Inc. Information
| Industry | INDUSTRIAL ORGANIC CHEMICALS |
| Employees | 146 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Codexis, Inc. (CDXS) Stock on MEXC
Eligible investors can buy real shares of Codexis, Inc. (CDXS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Codexis, Inc. (CDXS) stock price today?
2.Is CDXS stock going up or down today?
3.What is CDXS pre-market price?
4.What is CDXS after-hours price?
5.Is CDXS stock trading now?
6.Where does CDXS sit relative to its 52-week high and low?
7.What sector is Codexis, Inc. in?
8.What is Codexis, Inc.'s market capitalization and where is it listed?
9.How is CDXS valued in terms of P/E ratio and EPS?
10.Does Codexis, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
CDXS Stock Calculator
Estimate the value between CDXS shares and USD.
CDXS Shares to USD
1.00 CDXS shares = 1.31 USD
Calculations are estimates based on the latest available price and are for reference only.



